Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

NCT06472817 | Enrolling By Invitation

• 4 other identifiers: 22-005329NCI-2024-0399617109W81XWH-22-1-0971
• Study Type: observational
• Target: 80
• Locations: 1 country
• Sites: 2

Brief Summary

This study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from Sub-Sahara Africa affects the experiences of participants regarding health-seeking behaviors, care, and treatment of prostate cancer. It also examines similarities and differences among participants based on their region of origin in Africa.

Conditions

Prostate Carcinoma

Outcome Measures

Primary Outcomes (2)

• Qualitative Interview - identification of themes and constructs

  Data will be collected during an in-depth interview and will be analyzed with an inductive, open coding approach, first identifying themes, then constructs that emerge from the data will be categorized and mapped, noting new concepts and constructs. Theme convergence and divergence will be assessed. The interview guide focuses on participants' experiences and health-seeking behaviors regarding prostate cancer prevention, detection, decision-making, treatment, care, and survivorship.

  Baseline

• Immigrant social determinants of health factors that impact Sub-Saharan African Immigrant (SSAI) carcinoma of the prostate (CaP) survivors

  From the data generated in Outcome 1 interviews, an interpretive framework or theoretical model for SSAI men will be developed to evaluate and identify factors that contribute to or exacerbate disparities in prostate cancer.

  Baseline

Study Arms (1)

Observational

AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study. AIM II: Participants complete an interview in person, over the phone, or via zoom on study.

Other: Non-Interventional Study

Interventions

Non-Interventional Study OTHER

Non-interventional study

Observational

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Sub-Saharan African immigrant men who were diagnosed with prostate cancer.

You may qualify if:

• PHASE I:
• Adult men originally from each of these geographic regions (East, West, Central, and Southern Africa) and have been diagnosed with prostate cancer
• Able to provide written consent and conduct an interview
• Able to speak and understand English
• PHASE II:
• Caribbean Immigrant men and SSAI men diagnosed with CaP within the last 10 years who identify as Black and speak English
• Able to provide written consent and conduct an interview
• Able to speak and understand English

You may not qualify if:

• PHASE I:
• Patients below the ages of 18, and those not belonging to any of four regions
• Employees of Mayo Clinic will be excluded
• Non-English speakers will not be included
• PHASE II:
• Individuals below the age of 18
• Those not diagnosed with prostate cancer and individuals not from the regions described above
• Employees of Mayo Clinic will be excluded
• Non-English speakers will not be included

Sponsors & Collaborators

• Mayo Clinic: lead
• Congressionally Directed Medical Research Programs: collaborator

Study Sites (2)

Georgia State University

Atlanta, Georgia, 30302-3965, United States

Location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

• Mayo Clinic Clinical Trials

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Study Officials

• Gladys B. Asiedu, Ph.D.

  Mayo Clinic in Rochester

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 19, 2024
• First Posted: June 25, 2024
• Study Start: September 5, 2023
• Primary Completion (Estimated): September 11, 2026
• Study Completion (Estimated): September 11, 2026
• Last Updated: January 21, 2026

Record last verified: 2026-01

Locations

US (2)